Assessment of Assay for Rapid Identification of Bloodstream Infections From Whole Blood

Status unconfirmed

Conditions studied: Bacteremia, Candidemia

In brief

The purpose of this study is to assess the effectiveness of RaPID/BSI by testing its performance compared to blood cultures collected prospectively from consented subjects.

Key facts

Study ID

NCT04147975

Run by

HelixBind, Inc.

People needed

225

Starts

2019-10-01

Expected to finish

2020-10-30

Last updated by the study team

2019-11-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Determined to have a positive blood culture.

Where it is running

• HelixBind Inc. — Marlborough, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.